Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up – Should You Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares gapped up before the market opened on Wednesday. The stock had previously closed at $10.25, but opened at $11.00. Ambu A/S shares last traded at $11.00, with a volume of 200 shares.

Analyst Ratings Changes

Separately, UBS Group lowered shares of Ambu A/S from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 15th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, Ambu A/S has an average rating of “Hold”.

Ambu A/S Stock Performance

The company has a market capitalization of $2.58 billion, a P/E ratio of 36.67 and a beta of 0.93. The firm has a 50 day moving average price of $10.79 and a two-hundred day moving average price of $10.36. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.69 and a current ratio of 2.77.

Ambu A/S (OTCMKTS:AMBBY) last issued its earnings results on Tuesday, August 25th. The company reported $0.09 earnings per share (EPS) for the quarter. The business had revenue of $255.12 million during the quarter. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. The company focuses on reducing the need to reprocess reusable equipment while supporting clinical procedures in areas such as endoscopy, anesthesia and patient monitoring.

Ambu’s product portfolio includes disposable endoscopes and related visualization systems, airway management products, anesthesia equipment and devices used for patient monitoring and diagnostics.